Lyphe Launches V Range: Affordable, Reliable, and Future-Ready Medical Cannabis
Lyphe has launched the V range of medical cannabis products. In this press release they provide all the key information.
66 pieces for Volteface.
Lyphe has launched the V range of medical cannabis products. In this press release they provide all the key information.
Discover how Germany's innovative cannabis pilot programme is reshaping regulation and driving industry growth.
Discover the latest MHRA guidelines set to reshape the UK medical cannabis market, covering new regulations on product naming and packaging.
In this article we examine the traffic data from Medbud for August - giving us a snapshot of the UK medical cannabis market.
The UK government's use of stigmatising language like "zombie drug" in its communication about the xylazine ban is harmful.
"Learn how landlords risk breaching the Equality Act 2010 by restricting tenants' use of prescribed medical cannabis.
In this articles we explore how Trump's new position on cannabis might impact the US cannabis policy landscape.
Why Labours proposed disposable vape ban is a blow to harm reduction. We need empowerment not paternalism to reduce harm.
Overdose Awareness Day, observed annually on the 31st of August, is a critical event for raising awareness about the growing issue.
Can the UK medical cannabis market hit 300k patients by 2028? To do so we will need better growth than any other medical cannabis market.
Why Labour's proposed smoking ban is an attack on personal freedom and the pub trade. If you care about drug policy reform this is a concern.
Critical DEA cannabis hearing delayed due to 43,500 public comments. The decision could now sit with Trump or Harris
New Data Shows Legalisation Reduces Cannabis Use. The UK should follow suit and take note: Volteface opinion piece
Ukraine’s Medical Cannabis Laws Need to Reflect the Realities of War. In this opinion piece Paul North outlines what needs changing and why
How do we convert illicit medical cannabis patient to the UK legal market in 2025. Let's examine the a case study and find out.
Welcome to our monthly breakdown of viewership statistics with MedBud.wiki, taking a deeper look at UK medical cannabis data for July 2024.
Ohio has legalised cannabis for recreational use, but Europe is lagging behind - instead held back by the public health lobby
Cannabis Industry News Show brought to you by Volteface. In this episode we discuss First Wednesdays report and the latest industry news.
In this article Paul North discusses the history and evolution of Volteface. The organisation has gone through several iterations since 2015.
Paul North reflects on the progress of UK medical cannabis since 2018, and proposes solutions for its future...
Paul North and guest Alfredo Pascual discuss where Europe is at with regards to recreational cannabis reform.
Paul North, Director of Volteface speaks to Arjun Rajyagor, CTO and Founder of Script Assist about how to improve cannabis prescribing.
On Volteface TV, Paul and Katya discuss why the UK politicians won't openly support UK drug policy reform and what can be done.
Cannabis legalisation in Germany update: Paul North on whether the EU will influence cannabis legalisation in Germany.